July 08, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

Conexiant

July 08, 2026

Standardizing Myopia Control

A new joint position statement urges ophthalmologists and optometrists to standardize contact lens-based myopia control

The Ophthalmologist

July 07, 2026

IOP Spikes During Hemodialysis

Researchers identify transient intraocular pressure spikes and falling ocular perfusion during hemodialysis

The Ophthalmologist

July 01, 2026

Optimizing MIGS for Practice and Center Success

The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.

Ophthalmology Management

July 01, 2026

How to Stay at the Forefront of Ophthalmology

Forty-four years in, Heaton Eye is still learning, but its foundation hasn't changed. "We believe in the technologies we offer, we prepare our team for success, and we let the outcomes do the rest."

Ophthalmology Management

June 29, 2026

The Fellow Eye Is Never Just a Bystander

What does the “fellow eye effect” reveal about ophthalmology’s pre-existing notions of unilateral eye disease?

The Ophthalmologist

June 28, 2026

Blindness Linked to Higher Loneliness Scores

Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.

Conexiant

June 26, 2026

New CEO for Optos

Optos appoints Alexandre Montague as Chief Executive Officer

The Ophthalmologist

June 25, 2026

Building on AI Foundations

Systematic review examines how foundation models could potentially reshape clinical decision-making and ophthalmic diagnostics

The Ophthalmologist

June 23, 2026

EGS Leaders Chart the Future of Glaucoma Care

Incoming and outgoing EGS presidents discuss the technologies, challenges, and priorities shaping the future of glaucoma care

The Ophthalmologist